University of Houston University of Houston Home Search

SEARCH

QUICK LINKS

Contact Us
Advising
UH Campus
Maps/Directions
College Directory

 

 

 

Course of Study Leading to a Pharm.D. Degree

YEAR I
SEMESTER II

CELLULAR LIFE SCIENCES II
PHAR 4401

Course Description: A study of human immunology as it relates to normal body function, disease states, and drug therapy.

Prerequisite: PHAR 4400, Cellular Life Sciences I

Course Proficiencies: In order to explain and discuss basic fundamentals of immunology so as to provide the basis for understanding the pathophysiology of immune diseases and to provide a rationale for the pharmacological and immunological management of immune diseases the student will be able to:

  1. Describe the origin, function, and significance of  the cells  of the immune system including stem cells, myeloid cells and lymphoid cells.
  2. Explain the function and significance of phagocytic cells, killing mechanisms of phagocytic cells, the R.E.S. system and the mechanisms of leukocyte margination and diapedesis including the role of chemotactic stimuli, F-actin, and adhesion molecules in the responses.
  3. Describe the function and significance of auxiliary myeloid cells (platelets, mast cells) and  their role in allergic reactions and inflammation including bronchial hyperactivity reactions.
  4. Define the function of the complement proteins system in humoral defense including their role and mechanisms of action in adherence reactions (opsonization), chemotaxis, mast cell degranulation and cytolysis in complement-mediated acute allergic/inflammatory responses.
  5. Describe the function and significance of primary lymphoid tissue (thymus and bone marrow); origin of B-cells and T-cells; the concept acquired immunological memory, memory cells and effector cells; secondary lymphoid tissue (spleen, lymph nodes, tonsils, adenoids, MALT, Peyer’s patch of the intestine); and sites of antigen presentation to lymphoid cells. 
  6. Define and differentiate between immunogens and antigens, haptens and immunogens, carrier molecules and antigens.
  7. Explain the function and significance of MHC antigens (Class I MHC, Class II MHC), antigen presenting cells, mechanisms of antigen  and MHC interactions, function of the major cytokines and the specificity of acquired immunity.
  8. Define the function and significance of T lymphocytes (Tc cells, Th cells, Ts cells) in  defense against intracellular invaders, role of assessory molecules in T cell activation, mechanisms of antigen specific activation and clonal expansion of T lymphocytes, and the mechanisms of antigen independent activation of T cells.
  9. Describe and differentiate between the mechanisms of cell-mediated immunity provided by cytotoxic T cells, NK cells, ADCC, extracellular killing by phagocytic cells and eosinophils.
  10. Define the cellular basis and describe the mechanisms of antigen specific activation of B-lymphocytes, mechanism(s) of clonal expansion of B lymphocytes, the functions of immunoglobulins IgG, IgA, IgM, IgD, and IgE, the mechanisms of activation of B cells by T-dependent antigens, and the         mechanisms of activation of B cells by T-independent antigens.
  11. Describe and explain the function and significance of the primary response to antigen challenge versus   the secondary response to antigen challenge, the role of adjuvants in antibody production and the immunological basis of vaccinations and protection against specific microbial invaders by the process of vaccination.
  12. Describe the mechanisms of antibody protection against microbial invaders (antigen specific humoral immunity) including the mechanisms of complement activation, mast cell degranulation, enhancement of cell medicated cytotoxicity (ADCC), neutralization reactions and facilitation of phagocytosis.
  13. Compare and contrast between the sites and mechanisms of action of utilized for the treatment of pain including the opioid receptor antagonists, acetaminophen and the NSAIDs.
  14. Distinguish between the five different classes of NSAIDs in terms of solubility, distribution, metabolism and side-effects.
  15. Discuss the origin of migraine and cluster agents and describe the site and mechanism of action of the 5-HT agonists and the cerebral vasoconstrictors.
  16. Compare and contrast between the site and mechanism of action, indications and side-effects of agents utilized to treat gout including colchicine, NSAIDs, uricosuric agents and xanthine oxidase inhibitors.
  17. Compare and contrast between the sites and mechanism of action, salient chemical features and metabolism of mast cell stabilizers, beta-2 agonists, anticholinergics, leukotriene inhibitors, xanthines and steroidal anti-inflammatory agents utilized for the treatment of asthma and COPD.
  18. Describe the chemical classes and the effects of various chemical substituents on the prototype molecule of the H-1 receptor antagonists.
  19. Discuss information that should be relayed to patients on the proper use of oral and nasal steroids.
  20. Discuss the side-effects, indications, contraindications, drug interactions and necessary information that should be relayed to patients regarding antihistamines, decongestants, theophylline, corticosteroids, beta-2 agonists and ipratropium for the treatment of allergic rhinitis, asthma and COPD.
  21. Compare and contrast between the sites and mechanism of action, salient chemical features, metabolism and side-effects of agents utilized for the treatments of allergic rhinitis including sedating and non-sedating antihistamines and mast cell inhibitors.
  22. Compare and contrast between the sites and mechanism of action, physical and chemical properties and metabolism of the cytoprotective agents, chemical complexing agents, H-2 receptor antagonists and proton pump inhibitors utilized for the treatment of GI disorders.
  23. Discuss the side-effects, indications, contraindications, drug interactions and necessary information that should be relayed to patients regarding the cytoprotective agents, H-2 receptor antagonists and proton pump inhibitors utilized for the treatment of GI disorders.
  24. Describe which drug treatments may be utilized for the treatment of H.pylori.
  25. Discuss the drugs that are utilized for the treatment of ulcerative colitis and Crohn’s disease in terms of mechanism of action and potential side-effects.
  26. Describe the mechanism and therapeutic use of the major cytokines/ monoclonal antibodies used as therapeutic agents.
  27. Describe the basic immune mechanism of the most prevalent immune diseases (hypersensitivity reactions, graft rejection reactions, immunodeficiency diseases, and cancer), the rationale of immune or pharmacological approaches to the management of immune disease, and the mechanism of action of immunopharmcological agents used in the treatment of these diseases.
  State of Texas Privacy and Policies Homeland Security Reporting Copyright Infringement Contact U H Feedback Site Map Statewide Search U H System Compact with Texas University of Houston